Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Cancer
|
October 9, 2025
Reply to "From treatment escalation to ultra de-intensification: When androgen-deprivation therapy alone remains a rational choice in metastatic hormone-sensitive prostate cancer"
Irene Tsung, Zachery R Reichert
Cancer Journal (Sudbury, Mass.)
|
October 18, 2016
Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer
Zachery R Reichert, Maha Hussain
Current Opinion in Urology
|
June 4, 2019
Clinical implications of genetic aberrations in metastatic prostate cancer
Zachery R Reichert, Rana R McKay
Cancer Journal (Sudbury, Mass.)
|
January 25, 2020
Clinically Lymph Node Positive Prostate Cancer: At the Intersection of Focal and Systemic Disease Control
Zachery R Reichert, Robert T Dess
Cancer
|
April 3, 2015
Addressing apoptosis to tumor zip codes
Zachery R Reichert, Maha H A Hussain
JAMA Oncology
|
December 28, 2018
Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer
Zachery R Reichert, Joshua Urrutia, Joshi J Alumkal
Cancer
|
August 7, 2025
Controversies in metastatic hormone-sensitive prostate cancer
Irene Tsung, Sarah E Yentz, Zachery R Reichert
JAMA Oncology
|
November 5, 2020
A CHIP in the Armor of Cell-Free DNA-Based Predictive Biomarkers for Prostate Cancer
Zachery R Reichert, Morgan A Jones, Joshi J Alumkal
Seminars in Radiation Oncology
|
September 14, 2016
Translation of Targeted Radiation Sensitizers into Clinical Trials
Zachery R Reichert, Daniel R Wahl, Meredith A Morgan
The American Journal of Case Reports
|
May 12, 2020
Upper Gastrointestinal Bleeding Due to a Duodenal Metastasis from Primary Testicular Squamous Cell Carcinoma
Juan J Gonzalez, Ahsan Wahab, Emelie Gonzalez, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Cancer
|
October 9, 2025
Reply to "From treatment escalation to ultra de-intensification: When androgen-deprivation therapy alone remains a rational choice in metastatic hormone-sensitive prostate cancer"
Irene Tsung, Zachery R Reichert
Cancer Journal (Sudbury, Mass.)
|
October 18, 2016
Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer
Zachery R Reichert, Maha Hussain
Current Opinion in Urology
|
June 4, 2019
Clinical implications of genetic aberrations in metastatic prostate cancer
Zachery R Reichert, Rana R McKay
Cancer Journal (Sudbury, Mass.)
|
January 25, 2020
Clinically Lymph Node Positive Prostate Cancer: At the Intersection of Focal and Systemic Disease Control
Zachery R Reichert, Robert T Dess
Cancer
|
April 3, 2015
Addressing apoptosis to tumor zip codes
Zachery R Reichert, Maha H A Hussain
JAMA Oncology
|
December 28, 2018
Microsatellite Instability as an Emerging Biomarker for Checkpoint Inhibitor Response in Advanced Prostate Cancer
Zachery R Reichert, Joshua Urrutia, Joshi J Alumkal
Cancer
|
August 7, 2025
Controversies in metastatic hormone-sensitive prostate cancer
Irene Tsung, Sarah E Yentz, Zachery R Reichert
JAMA Oncology
|
November 5, 2020
A CHIP in the Armor of Cell-Free DNA-Based Predictive Biomarkers for Prostate Cancer
Zachery R Reichert, Morgan A Jones, Joshi J Alumkal
Seminars in Radiation Oncology
|
September 14, 2016
Translation of Targeted Radiation Sensitizers into Clinical Trials
Zachery R Reichert, Daniel R Wahl, Meredith A Morgan
The American Journal of Case Reports
|
May 12, 2020
Upper Gastrointestinal Bleeding Due to a Duodenal Metastasis from Primary Testicular Squamous Cell Carcinoma
Juan J Gonzalez, Ahsan Wahab, Emelie Gonzalez, et al.
Page
of 6